Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
3
×
acute myeloid leukemia
boston blog main
boston top stories
clinical trials
san francisco blog main
adverum biotechnologies
ally bridge group
alx oncology
ambit biosciences
athena countouriotis
autoimmune diseases
berkeley lights
big data analytics
biotech ipos
blackrock
boston
brett zbar
bristol-myers squibb
cancer drugs
cancer immunotherapy
casdin capital
cd47
chronic kidney disease
cormorant asset management
daiichi sankyo
deals
deerfield healthcare technology acquisitions
deerfield management company
diabetic nephropathy
europe blog main
europe top stories
eventide asset management
fda
focal segmental glomerulosclerosis
goldfinch bio
halozyme therapeutics
What
biotech
3
×
new
raised
3
×
drug
ipo
million
analysis
arrival
athena
bio
bring
cancer
ceo
chief
companies
company
countouriotis
days
develop
diseases
employing
financing
genetic
gets
goldfinch
hasn’t
industry
ipos
kidney
later
lead
life
market
medical
medicines
mezzanine
momentum
names
officer
old
Language
unset
Current search:
biotech
×
raised
×
" national top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push